Wirus zapalenia wątroby typu A (HAV) - czynnik etiologiczny infekcji pokarmowych człowieka

• Autorzy: Bigoraj E. , Chrobocinska M.

Warianty tytułu

EN

Hepatitis A virus (HAV): an etiological agent of food borne human infection

• Języki publikacji: PL

Abstrakty

EN

Hepatitis A virus (HAV) is the most common cause of hepatitis in humans all over the world. Non-enveloped HAV is classified to the Picornaviridae family. The virus is highly resistant to physico-chemical factors. The genome contains the single-strand RNA encoding a long polyprotein. This polyprotein is used to form four structural and seven non-structural proteins in the post translating process. All polyprotein cleavage sites have not been identified, yet infection with HAV frequently occurs through the consumption of contaminated food or water. The disease is often asymptomatic in young children. In older children and adults different clinical symptoms may be observed, from mild (without jaundice) to severe liver failure. In many regions of the world the disease occurs endemically and in developed countries outbreaks and epidemics are noted. Inactivated vaccines are used in specific protection.

Słowa kluczowe

PL

choroby czlowieka; drogi zakazenia; epidemiologia; genomy; infekcja wirusowa; objawy chorobowe; wirus zapalenia watroby typu A; wirusowe zapalenie watroby typu A

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2010
• Tom: 66
• Numer: 07
• Opis fizyczny: s.439-443,rys.,fot.,tab.,bibliogr.

Twórcy

autor

Bigoraj E.

• Zakład Wirusologii Żywności i Środowiska, Państwy Instytut Weterynaryjny - Państwowy Instytut Badawczy, Al. Partyzantów 57, 24-100 Puławy

autor

Chrobocinska M.

Bibliografia

• 1.Anon.: Centers for Disease Control and Prevention. Prevention of hepatitis A through active or passive immunisation: recommendations of the Advisory Committee on Immunisation Practices (ACIP) MMWR 1999, 48 (Nr RR-12), 1-38.
• 2.Anon.: Consensus Statement Backgrounder I: VHPB Consensus Statement on the Control of Hepatitis A: Centre for the Evaluation of Vaccination WHO Collaborating Centre for Prevention and Control of Viral Hepatitis.
• 3.Anon.: World Health Organization Department of Communicable Disease Surveillance and Response WHO/CDS/CSR/EDC/2000.7.
• 4.Ashida M., Hamada C.: Molecular cloning of the hepatitis A virus receptor from a simian cell line. J. Gen. Virol. 1997, 78, 1565-1569.
• 5.Baumann A.: Wirusowe zapalenie wątroby typu A w Polsce w latach 2006-2007. Przegl. Epidemiol. 2009, 63, 241-244.
• 6.Belsham G. J.: Divergent picornavirus IRES elements. Virus Res. 2009, 183-192.
• 7.Brown E. A., Day S. P., Jansen R. W., Lemon S. M.: The 5' nontranslated region of hepatitis A virus RNA: secondary structure and elements required for translation in vitro. J. Virol. 1991, 65, 5828-5838.
• 8.Částková J., Beneš C.: Increase in hepatitis A cases in the Czech Republic in 2008 - an update. Euro Surveill. 2009, 14, 1-3.
• 9.Cristina J., Costa-Mattioli M.: Genetic variability and molecular evolution of hepatitis A virus. Virus Res. 2007, 127, 151-157.
• 10.Duszczyk E.: Wirusowe zapalenie wątroby typu A - epidemiologia, klinika, leczenie, zapobieganie. Przew. Lek. 2001, 4, 64-67.
• 11.Emerson S. U., Huang Y. K., Purcell R. H.: 2B and 2C mutations are essential but mutations throughout the genome of HAV contribute to adaptation to cell culture. Virol. 1993, 194, 475-480.
• 12.Feinstone S. M., Kapikian A. Z., Purcell R. H.: Hepatitis A: detection by immune electron microscopy of a virus-like antigen associated with acute illness. Science 1973, 182, 1026-1028.
• 13.Fiore A. E., Wasley A., Bell B. P.: Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 2006, 55, RR-7.
• 14.García-Aguirre L., Cristina J.: Analysis of the full-length genome of hepatitis A virus isolated in South America: heterogeneity and evolutionary constraints. Arch. Vir. 2008, 153, 1473-1478.
• 15.Harmon S. A., Richards O. C., Summers D. F., Ehrenfeld E.: The 5'-terminal nucleotides of hepatitis A virus RNA, but not poliovirus RNA, are required for infectivity. J. Virol. 1991, 65, 2757-2760.
• 16.Kaplan G., Totsuka A., Thompson P., Akatsuka T., Moritsugu Y., Feinstone S. M.: Identification of a surface glycoprotein on African green monkey kidney cells as a receptor for hepatitis A virus. EMBO J. 1996, 15, 4282-4296.
• 17.Knipe D. M., Howley P. M.: Fields Virology. T. 2, Philadelphia, USA 2007, 911-940.
• 18.Kozak M.: Regulation of translation in eucariotic systems. Annu. Rev. Cell Biol. 1992, 8, 197-225.
• 19.Kramer A., Schwebke I., Kampf G.: How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect. Dis. 2006, 6, 1-8.
• 20.Lemon S. M., Binn L. N.: Incomplete neutralization of hepatitis A virus in vitro due to lipid-associated virions. J. Gen. Virol. 1985, 66, 2501-2505.
• 21.Magdzik W.: Wirusowe zapalenie w¹troby typu A (wzw A) w 2003 roku. Przegl. Epidemiol. 2005, 59, 289-295.
• 22.Martin A., Lemon S. M.: Hepatitis A virus: from discovery to vaccines. Hepatology 2006, 43, 164-172.
• 23.Morace G., Kusov Y., Dzagurov G., Beneduce F., Gauss-Müller V.: The unique role of domain 2A of the hepatitis A virusprecursor polypeptide P1-2A in viral morphogenesis. BMB, Rep. 2008, 41, 678-683.
• 24.Mrozińska M., Miksa G.: Wirusowe zapalenie wątroby typu A - nowoczesna, skuteczna, bezpieczna metoda zwalczania epidemii wzw A. Przew. Lek. 2002, 5, 18-20.
• 25.Paul A. V., Rieder E., Kim D. W., Van Boom J. H., Wimmer E.: Identification of an RNA hairpin in poliovirus RNA that serves as the primary template in the in vitro uridylylation of VPg. J. Virol. 2000, 74, 10359-10370.
• 26.Peters H., Kusov Y. Y., Meyer S., Benie A. J., Bäuml E., Wolff M., Rademacher C., Peters T., Gauss-Müller V.: Hepatitis A virus proteinase 3C binding to viral RNA: correlation with substrate binding and enzyme dimerization. Biochem. J. 2005, 385, 363-370.
• 27.Probst C., Jecht M., Gauss-Muller V.: Intrinsic signals for the assembly of hepatitis A virus particles. J. Biol. Chem. 1999, 274, 4527-4531.
• 28.Robertson B. H., Jansen R. W., Khanna B., Totsuka A., Nainan O. V., Siegl G., Widell A., Margolis H. S., Isomura S., Ito K., Ishizu T., Moritsugu Y., Lemon S. M.: Genetic relatedness of hepatitis A virus strains recovered from different geographical regions. J. Gen. Virol. 1992, 73, 1365-1377.
• 29.Seymour I. J., Appleton H.: Foodborne viruses and fresh produce. J. Appl. Microbiol. 2001, 91, 759-773.
• 30.Siegl G., Weitz M.: Pathogenesis of hepatitis A: persistent viral infection as basis of an acute disease? Microb. Pathog. 1993, 14, 1-8.
• 31.Silberstein E., Dveksler G., Kaplan G. G.: Neutralization of hepatitis A virus (HAV) by an immunoadhesin containing the cysteine-rich region of HAV cellular receptor-1. J. Virol. 2001, 75, 717-725.
• 32.Tami C., Silberstein E., Manangeeswaran M., Freeman G. J., Umetsu S. E., DeKruyff R. H., Umetsu D. T., Kaplan G. G.: Immunoglobulin A (IgA) is a natural ligand of hepatitis A virus cellular receptor 1 (HAVCR1), and the association of IgA with HAVCR1 enhances virus-receptor interactions. J. Virol. 2007, 81, 3437-3446.
• 33.Totsuka A., Moritsugu Y.: Hepatitis A virus proteins. Intervirol. 1999, 42, 63-68.
• 34.Vallbracht A., Maier K., Stierhof Y. D., Wiedmann K. H., Flehmig B., Fleischer B.: Liver-derived cytotoxic T cells in hepatitis A virus infection. J. Infect. Dis. 1989, 160, 209-217.
• 35.Zhang H., Chao S. F., Ping L. H., Grace K., Clarke B., Lemon S. M.: An infectious cDNA clone of a cytopathic hepatitis A virus: Genomic regions associated with rapid replication and cytopathic effect. Virol. 1995, 212, 686-697.